APLM revenueFY2025$8.50M
APLM revenue was $8.50M for fiscal 2025 (ended Dec 31, 2025), compared with $0 in fiscal 2024. Fiscal 2025 is the highest of the 6 fiscal years on file.
Apollomics Inc. (APLM) financials
For fiscal 2025 (ended Dec 31, 2025), Apollomics Inc. reported $8.50M of revenue and -$10.94M of net income.
- Revenue, FY2025
- $8.50M
- Net income, FY2025
- -$10.94M
- Net margin
- -128.7%
- EPS, diluted, FY2025
- -$7.57
- Cash
- $3.28M
- Total debt
- $0
- P/S
- 6.22
- Market cap
- $52.9M
FY2020FY2025
FY2020FY2025
FY2020FY2024
APLM revenue and earnings growth
APLM net incomeFY2025-$10.94M
APLM net income was -$10.94M for fiscal 2025 (ended Dec 31, 2025), compared with -$53.86M in fiscal 2024.
APLM EPSFY2025-$7.57
APLM diluted EPS was -$7.57 for fiscal 2025 (ended Dec 31, 2025).
APLM free cash flowFY2024-$28.77M
APLM free cash flow was -$28.77M for fiscal 2024 (ended Dec 31, 2024), compared with -$43.22M in fiscal 2023.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | $8.50M | $0 | $0 | $0 | $0 | $0 |
| Research and development | $5.53M | $24.57M | $34.19M | $35.46M | $35.57M | $31.44M |
| Selling, general and admin | $12.44M | $17.77M | $20.64M | $9.95M | $15.29M | $11.04M |
| Operating income | - | - | - | $976.0K | - | - |
| Interest expense | $65.0K | $179.0K | $150.0K | $93.0K | $83.0K | $72.0K |
| Pre-tax income | -$10.94M | -$53.60M | -$172.59M | -$240.81M | -$94.80M | -$74.91M |
| Income tax | $3.0K | $259.0K | $10.0K | $1.0K | $1.0K | -$85.0K |
| Net income | -$10.94M | -$53.86M | -$172.60M | -$240.81M | -$94.80M | -$74.82M |
| EPS, basic | -$7.57 | -$52.80 | -$231.99 | -$844.95 | -$337.00 | -$301.00 |
| EPS, diluted | -$7.57 | -$52.80 | -$231.99 | -$844.95 | -$337.00 | -$301.00 |
| Diluted shares | 1.4M | 1.0M | 744,000 | 285,000 | 281,070 | 252,195.349 |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $3.28M | $9.77M | $32.06M | $32.67M | $46.74M | $130.65M |
| Short-term investments | - | $0 | $5.76M | $19.07M | $23.74M | - |
| Current assets | $6.05M | $10.27M | $39.92M | $55.79M | $99.37M | - |
| Total assets | $6.71M | $13.10M | $55.39M | $76.47M | $123.44M | - |
| Current liabilities | $6.33M | $7.40M | $13.56M | $12.36M | $13.56M | - |
| Total debt | $0 | $0 | - | - | - | - |
| Total liabilities | - | - | - | $448.12M | - | - |
| Shareholders' equity | -$3.19M | $4.86M | $41.23M | -$448.12M | -$212.86M | -$127.93M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$10.37M | -$28.74M | -$43.21M | -$42.82M | -$43.31M | -$35.68M |
| Capital expenditures | - | $24.0K | $6.0K | $367.0K | $50.0K | $144.0K |
| Free cash flow | - | -$28.77M | -$43.22M | -$43.19M | -$43.36M | -$35.83M |
| Investing cash flow | $218.0K | $5.98M | $21.36M | $29.05M | -$38.95M | $2.33M |
| Financing cash flow | $3.68M | $468.0K | $21.23M | -$294.0K | -$1.64M | $125.51M |
| Stock-based compensation | -$979.0K | $10.93M | $12.69M | $3.58M | $8.12M | $4.51M |
Key ratios
Source: XBRL data Apollomics Inc. files with the SEC, latest filing dated Apr 24, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 3-for-43, first reported Mar 28, 2024; 1-for-100, first reported Apr 3, 2025.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
APLM peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| APLM | $8.50M | - | -$10.94M | -128.7% | $52.9M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.33T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $679.13B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $518.44B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $366.73B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $312.35B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $293.69B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.40B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $183.23B |
APLM FAQ
6 questionsWhat is APLM revenue?
Apollomics Inc. (APLM) reported $8.50M of revenue for fiscal 2025 (ended Dec 31, 2025).Is APLM profitable?
No. Apollomics Inc. reported a net loss of $10.94M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does APLM have?
Apollomics Inc. reported $3.28M in cash and cash equivalents and $0 of debt on its most recent balance sheet in SEC filings.What is APLM earnings per share?
Diluted earnings per share were -$7.57 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did APLM last report financial results?
The latest statements here come from Apollomics Inc.'s 20-F filed on Apr 24, 2026, covering the period ended Dec 31, 2025.Where does this APLM financial data come from?
Quantisnow builds these statements from the structured XBRL data Apollomics Inc. files with the SEC. It is provided for information only and is not investment advice.